{
  "12T_NT1.raw": {
    "Source Name": [
      "12T_NT1"
    ],
    "Assay Name": [
      "12T_NT1_assay"
    ],
    "Raw Data File": [
      "12T_NT1.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT1"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_NT3.raw": {
    "Source Name": [
      "12T_NT3"
    ],
    "Assay Name": [
      "12T_NT3_assay"
    ],
    "Raw Data File": [
      "12T_NT3.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT3"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_OE2.raw": {
    "Source Name": [
      "A375_OE2"
    ],
    "Assay Name": [
      "A375_OE2_assay"
    ],
    "Raw Data File": [
      "A375_OE2.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE2"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_NT2.raw": {
    "Source Name": [
      "12T_NT2"
    ],
    "Assay Name": [
      "12T_NT2_assay"
    ],
    "Raw Data File": [
      "12T_NT2.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT2"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_IFN1.raw": {
    "Source Name": [
      "108T_IFN1"
    ],
    "Assay Name": [
      "108T_IFN1_assay"
    ],
    "Raw Data File": [
      "108T_IFN1.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN1"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_EV2.raw": {
    "Source Name": [
      "108T_EV2"
    ],
    "Assay Name": [
      "108T_EV2_assay"
    ],
    "Raw Data File": [
      "108T_EV2.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV2"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_OE1.raw": {
    "Source Name": [
      "108T_OE1"
    ],
    "Assay Name": [
      "108T_OE1_assay"
    ],
    "Raw Data File": [
      "108T_OE1.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE1"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_IFN2.raw": {
    "Source Name": [
      "108T_IFN2"
    ],
    "Assay Name": [
      "108T_IFN2_assay"
    ],
    "Raw Data File": [
      "108T_IFN2.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN2"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_EV1.raw": {
    "Source Name": [
      "108T_EV1"
    ],
    "Assay Name": [
      "108T_EV1_assay"
    ],
    "Raw Data File": [
      "108T_EV1.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV1"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_EV3.raw": {
    "Source Name": [
      "108T_EV3"
    ],
    "Assay Name": [
      "108T_EV3_assay"
    ],
    "Raw Data File": [
      "108T_EV3.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV3"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_IFN3.raw": {
    "Source Name": [
      "12T_IFN3"
    ],
    "Assay Name": [
      "12T_IFN3_assay"
    ],
    "Raw Data File": [
      "12T_IFN3.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN3"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_OE3.raw": {
    "Source Name": [
      "12T_OE3"
    ],
    "Assay Name": [
      "12T_OE3_assay"
    ],
    "Raw Data File": [
      "12T_OE3.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE3"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_IFN3.raw": {
    "Source Name": [
      "108T_IFN3"
    ],
    "Assay Name": [
      "108T_IFN3_assay"
    ],
    "Raw Data File": [
      "108T_IFN3.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN3"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_EV3.raw": {
    "Source Name": [
      "A375_EV3"
    ],
    "Assay Name": [
      "A375_EV3_assay"
    ],
    "Raw Data File": [
      "A375_EV3.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV3"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_EV2.raw": {
    "Source Name": [
      "12T_EV2"
    ],
    "Assay Name": [
      "12T_EV2_assay"
    ],
    "Raw Data File": [
      "12T_EV2.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV2"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_IFN1.raw": {
    "Source Name": [
      "12T_IFN1"
    ],
    "Assay Name": [
      "12T_IFN1_assay"
    ],
    "Raw Data File": [
      "12T_IFN1.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN1"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_OE2.raw": {
    "Source Name": [
      "108T_OE2"
    ],
    "Assay Name": [
      "108T_OE2_assay"
    ],
    "Raw Data File": [
      "108T_OE2.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE2"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_OE2.raw": {
    "Source Name": [
      "12T_OE2"
    ],
    "Assay Name": [
      "12T_OE2_assay"
    ],
    "Raw Data File": [
      "12T_OE2.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE2"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_EV1.raw": {
    "Source Name": [
      "A375_EV1"
    ],
    "Assay Name": [
      "A375_EV1_assay"
    ],
    "Raw Data File": [
      "A375_EV1.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV1"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_OE1.raw": {
    "Source Name": [
      "12T_OE1"
    ],
    "Assay Name": [
      "12T_OE1_assay"
    ],
    "Raw Data File": [
      "12T_OE1.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE1"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_EV3.raw": {
    "Source Name": [
      "12T_EV3"
    ],
    "Assay Name": [
      "12T_EV3_assay"
    ],
    "Raw Data File": [
      "12T_EV3.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV3"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_OE3.raw": {
    "Source Name": [
      "108T_OE3"
    ],
    "Assay Name": [
      "108T_OE3_assay"
    ],
    "Raw Data File": [
      "108T_OE3.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE3"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_NT2.raw": {
    "Source Name": [
      "108T_NT2"
    ],
    "Assay Name": [
      "108T_NT2_assay"
    ],
    "Raw Data File": [
      "108T_NT2.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT2"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_NT1.raw": {
    "Source Name": [
      "108T_NT1"
    ],
    "Assay Name": [
      "108T_NT1_assay"
    ],
    "Raw Data File": [
      "108T_NT1.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT1"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "108T_NT3.raw": {
    "Source Name": [
      "108T_NT3"
    ],
    "Assay Name": [
      "108T_NT3_assay"
    ],
    "Raw Data File": [
      "108T_NT3.raw"
    ],
    "Characteristics[CellLine]": [
      "108T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "NT3"
    ],
    "FactorValue[Treatment]": [
      "non-treated"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_EV2.raw": {
    "Source Name": [
      "A375_EV2"
    ],
    "Assay Name": [
      "A375_EV2_assay"
    ],
    "Raw Data File": [
      "A375_EV2.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV2"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_OE1.raw": {
    "Source Name": [
      "A375_OE1"
    ],
    "Assay Name": [
      "A375_OE1_assay"
    ],
    "Raw Data File": [
      "A375_OE1.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE1"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "A375_OE3.raw": {
    "Source Name": [
      "A375_OE3"
    ],
    "Assay Name": [
      "A375_OE3_assay"
    ],
    "Raw Data File": [
      "A375_OE3.raw"
    ],
    "Characteristics[CellLine]": [
      "A375"
    ],
    "Characteristics[BiologicalReplicate]": [
      "OE3"
    ],
    "FactorValue[Treatment]": [
      "overexpressed both PSMB8 and PSMB9 (OE)"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_IFN2.raw": {
    "Source Name": [
      "12T_IFN2"
    ],
    "Assay Name": [
      "12T_IFN2_assay"
    ],
    "Raw Data File": [
      "12T_IFN2.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "IFN2"
    ],
    "FactorValue[Treatment]": [
      "treated with 250\u2009U/ml IFN\u03b3 (Peprotech) for 48\u2009h"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  },
  "12T_EV1.raw": {
    "Source Name": [
      "12T_EV1"
    ],
    "Assay Name": [
      "12T_EV1_assay"
    ],
    "Raw Data File": [
      "12T_EV1.raw"
    ],
    "Characteristics[CellLine]": [
      "12T"
    ],
    "Characteristics[BiologicalReplicate]": [
      "EV1"
    ],
    "FactorValue[Treatment]": [
      "empty vector control"
    ],
    "Characteristics[Organism]": [
      "human"
    ],
    "Characteristics[MaterialType]": [
      "cell line"
    ],
    "Characteristics[Disease]": [
      "metastatic melanoma tumor resections"
    ],
    "Characteristics[NumberOfBiologicalReplicates]": [
      "three experimental replicates per each cell line and each condition"
    ],
    "Characteristics[ReductionReagent]": [
      "1\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "0.2\u2009mM iodoacetamide"
    ],
    "Characteristics[CleavageAgent]": [
      "unspecific"
    ],
    "Comment[Instrument]": [
      "Q-Exactive-Plus (Thermo Fisher Scientific)",
      "UltiMate 3000 RSLCnano-capillary UHPLC system (Thermo Fisher Scientific)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent \u201ctop 10\u201d method"
    ],
    "Comment[FragmentationMethod]": [
      "higher-energy collisional dissociation (HCD)"
    ],
    "Comment[IonizationType]": [
      "electrospray"
    ],
    "Comment[GradientTime]": [
      "linear gradient over 2\u2009h"
    ],
    "Comment[FlowRateChromatogram]": [
      "0.15\u2009\u00b5l/min"
    ],
    "Comment[EnrichmentMethod]": [
      "HLA peptidomics",
      "HLA molecules were immunoaffinity purified"
    ],
    "Comment[CollisionEnergy]": [
      "Normalized collision energy was set to 25%"
    ]
  }
}